{"nct_id":"NCT04776252","title":"Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2021-09-15","start_date_type":"ACTUAL","primary_completion_date":"2028-05-17","primary_completion_date_type":"ESTIMATED","completion_date":"2028-05-17","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}